Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer

Hormone receptor-positive breast cancer is the most frequent breast cancer subtype. Endocrine therapy (ET) targeting the estrogen receptor (ER) pathway represents the main initial therapeutic approach. The major strategies include estrogen deprivation and the use of selective estrogen modulators or...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinert, Tomas, Saad, Everardo D., Barrios, Carlos H., Bines, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350138/
https://www.ncbi.nlm.nih.gov/pubmed/28361033
http://dx.doi.org/10.3389/fonc.2017.00026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350138/
https://www.ncbi.nlm.nih.gov/pubmed/28361033
http://dx.doi.org/10.3389/fonc.2017.00026

Ejemplares similares